Loading…

Pathogenicity of Trichosporon asahii in a murine model of disseminated trichosporonosis

Background In recent years, superficial and deep mycoses caused by trichosporon were occasionally reported. In 2001, we reported the first case of disseminated trichosporonosis caused by Trichosporon asahfi (T. asahii) in China. In this study, the pathogenicity of T. asahii was investigated in a mur...

Full description

Saved in:
Bibliographic Details
Published in:Chinese medical journal 2008-12, Vol.121 (24), p.2557-2560
Main Authors: Yang, Rong-ya, Wang, Wen-ling, Ao, Jun-hong, Hao, Zhen-feng, Zhang, Jie, Wang, Cong-min
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c421t-449da76b0d798967334880b97fdd5efa3ad05a71c90b444c0e8f096570255283
cites cdi_FETCH-LOGICAL-c421t-449da76b0d798967334880b97fdd5efa3ad05a71c90b444c0e8f096570255283
container_end_page 2560
container_issue 24
container_start_page 2557
container_title Chinese medical journal
container_volume 121
creator Yang, Rong-ya
Wang, Wen-ling
Ao, Jun-hong
Hao, Zhen-feng
Zhang, Jie
Wang, Cong-min
description Background In recent years, superficial and deep mycoses caused by trichosporon were occasionally reported. In 2001, we reported the first case of disseminated trichosporonosis caused by Trichosporon asahfi (T. asahii) in China. In this study, the pathogenicity of T. asahii was investigated in a murine model of disseminated trichosporonosis. Methods Seventy-five mice were randomly divided into 7 groups. Each group was inoculated with T. asahii, through intradermal, gastrointestinal tract or intravenous injection. The mice in the experimental groups were given an intraperitoneal injection of cyclophosphamide (CY) to induce granulocytopenia. Mice in the therapeutic group were given both liposomal amphotericin B and fluconazole. The main viscera of the mice were examined by means of tissue culture and pathologic sections. Results In the two intravenous inoculation groups, T. asahfi was isolated from at least one organ in 10 of the 12 granulocytopenic mice and 2 of the 14 immunocompetent mice. Two of the 7 mice in the granulocytopenia group presented with lesions in the inoculation position, but none of the 30 mice in the granulocytopenia and the control group which were inoculated intradermally or through the gastrointestinal tract had viscera infection. In the therapeutic group, the ratio of consequently dead mice, the number of involved viscera, and the incidence of systemic infection were significantly less than the untreated group. Acute purulent inflammation and granulomatous inflammation were the main pathological changes in the course of the infection. Arthrospores and filaments were found in the focus. Conclusions T. asahii is an opportunistic pathogen that causes cutaneous and visceral infections in immunologically impaired hosts. An immunocompetent host was to be infected by the invading T. asahii. Several organs, namely the liver, lungs, kidneys, spleen and heart, were predisposed. The therapy of combining liposomal amphotericin B with fluconazole can prevent the host from an infection and inhibit the diffusion of the infection.
doi_str_mv 10.1097/00029330-200812020-00016
format article
fullrecord <record><control><sourceid>wanfang_jour_cross</sourceid><recordid>TN_cdi_wanfang_journals_zhcmj200824016</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>29030391</cqvip_id><wanfj_id>zhcmj200824016</wanfj_id><sourcerecordid>zhcmj200824016</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-449da76b0d798967334880b97fdd5efa3ad05a71c90b444c0e8f096570255283</originalsourceid><addsrcrecordid>eNpNkMtOwzAQRS0EoqXwCyhiwS4wfsdLhHhJlWBRiaXlxE7j0sQlToXK1-PS8ljNaHTPjH0QyjBcYVDyGgCIohRyAlBgAgTyNMLiAI0JZyTnguFDNAYqRC6UUiN0EuMiQZxLcYxGWOFCcsXH6PXFDE2Yu85Xfthkoc5mva-aEFehD11momm8z3zqsnbd-85lbbBuuQ1aH6NrfWcGZ7PhHxWij6foqDbL6M72dYJm93ez28d8-vzwdHszzStG8JAzpqyRogQrVaGEpJQVBZRK1tZyVxtqLHAjcaWgZIxV4IoalOBy-xVS0Am63K39MF1turlehHXfpYP6s6naxVYPYUlMCha7YNWHGHtX61XvW9NvNAa9dap_nOpfp_rbaULPd-hqXbbO_oF7iSlwsd_dhG7-7tMzSlO91X7pNFFAgSpMvwDy9n1A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pathogenicity of Trichosporon asahii in a murine model of disseminated trichosporonosis</title><source>HEAL-Link subscriptions: Lippincott Williams &amp; Wilkins</source><creator>Yang, Rong-ya ; Wang, Wen-ling ; Ao, Jun-hong ; Hao, Zhen-feng ; Zhang, Jie ; Wang, Cong-min</creator><creatorcontrib>Yang, Rong-ya ; Wang, Wen-ling ; Ao, Jun-hong ; Hao, Zhen-feng ; Zhang, Jie ; Wang, Cong-min</creatorcontrib><description>Background In recent years, superficial and deep mycoses caused by trichosporon were occasionally reported. In 2001, we reported the first case of disseminated trichosporonosis caused by Trichosporon asahfi (T. asahii) in China. In this study, the pathogenicity of T. asahii was investigated in a murine model of disseminated trichosporonosis. Methods Seventy-five mice were randomly divided into 7 groups. Each group was inoculated with T. asahii, through intradermal, gastrointestinal tract or intravenous injection. The mice in the experimental groups were given an intraperitoneal injection of cyclophosphamide (CY) to induce granulocytopenia. Mice in the therapeutic group were given both liposomal amphotericin B and fluconazole. The main viscera of the mice were examined by means of tissue culture and pathologic sections. Results In the two intravenous inoculation groups, T. asahfi was isolated from at least one organ in 10 of the 12 granulocytopenic mice and 2 of the 14 immunocompetent mice. Two of the 7 mice in the granulocytopenia group presented with lesions in the inoculation position, but none of the 30 mice in the granulocytopenia and the control group which were inoculated intradermally or through the gastrointestinal tract had viscera infection. In the therapeutic group, the ratio of consequently dead mice, the number of involved viscera, and the incidence of systemic infection were significantly less than the untreated group. Acute purulent inflammation and granulomatous inflammation were the main pathological changes in the course of the infection. Arthrospores and filaments were found in the focus. Conclusions T. asahii is an opportunistic pathogen that causes cutaneous and visceral infections in immunologically impaired hosts. An immunocompetent host was to be infected by the invading T. asahii. Several organs, namely the liver, lungs, kidneys, spleen and heart, were predisposed. The therapy of combining liposomal amphotericin B with fluconazole can prevent the host from an infection and inhibit the diffusion of the infection.</description><identifier>ISSN: 0366-6999</identifier><identifier>EISSN: 2542-5641</identifier><identifier>DOI: 10.1097/00029330-200812020-00016</identifier><identifier>PMID: 19187595</identifier><language>eng</language><publisher>China: Department of Dermatology, General Hospital of Beijing Military Region of PLA, Beijing 100700, China</publisher><subject>Amphotericin B - therapeutic use ; Animals ; Antifungal Agents - therapeutic use ; Cyclophosphamide - therapeutic use ; Disease Models, Animal ; Fluconazole - therapeutic use ; Male ; Mice ; Mycoses - drug therapy ; Mycoses - microbiology ; Random Allocation ; Trichosporon - isolation &amp; purification ; Trichosporon - pathogenicity ; 动物模型 ; 毛孢子菌 ; 致病性 ; 阿萨希丝孢酵母</subject><ispartof>Chinese medical journal, 2008-12, Vol.121 (24), p.2557-2560</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-449da76b0d798967334880b97fdd5efa3ad05a71c90b444c0e8f096570255283</citedby><cites>FETCH-LOGICAL-c421t-449da76b0d798967334880b97fdd5efa3ad05a71c90b444c0e8f096570255283</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/85656X/85656X.jpg</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19187595$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Rong-ya</creatorcontrib><creatorcontrib>Wang, Wen-ling</creatorcontrib><creatorcontrib>Ao, Jun-hong</creatorcontrib><creatorcontrib>Hao, Zhen-feng</creatorcontrib><creatorcontrib>Zhang, Jie</creatorcontrib><creatorcontrib>Wang, Cong-min</creatorcontrib><title>Pathogenicity of Trichosporon asahii in a murine model of disseminated trichosporonosis</title><title>Chinese medical journal</title><addtitle>Chinese Medical Journal</addtitle><description>Background In recent years, superficial and deep mycoses caused by trichosporon were occasionally reported. In 2001, we reported the first case of disseminated trichosporonosis caused by Trichosporon asahfi (T. asahii) in China. In this study, the pathogenicity of T. asahii was investigated in a murine model of disseminated trichosporonosis. Methods Seventy-five mice were randomly divided into 7 groups. Each group was inoculated with T. asahii, through intradermal, gastrointestinal tract or intravenous injection. The mice in the experimental groups were given an intraperitoneal injection of cyclophosphamide (CY) to induce granulocytopenia. Mice in the therapeutic group were given both liposomal amphotericin B and fluconazole. The main viscera of the mice were examined by means of tissue culture and pathologic sections. Results In the two intravenous inoculation groups, T. asahfi was isolated from at least one organ in 10 of the 12 granulocytopenic mice and 2 of the 14 immunocompetent mice. Two of the 7 mice in the granulocytopenia group presented with lesions in the inoculation position, but none of the 30 mice in the granulocytopenia and the control group which were inoculated intradermally or through the gastrointestinal tract had viscera infection. In the therapeutic group, the ratio of consequently dead mice, the number of involved viscera, and the incidence of systemic infection were significantly less than the untreated group. Acute purulent inflammation and granulomatous inflammation were the main pathological changes in the course of the infection. Arthrospores and filaments were found in the focus. Conclusions T. asahii is an opportunistic pathogen that causes cutaneous and visceral infections in immunologically impaired hosts. An immunocompetent host was to be infected by the invading T. asahii. Several organs, namely the liver, lungs, kidneys, spleen and heart, were predisposed. The therapy of combining liposomal amphotericin B with fluconazole can prevent the host from an infection and inhibit the diffusion of the infection.</description><subject>Amphotericin B - therapeutic use</subject><subject>Animals</subject><subject>Antifungal Agents - therapeutic use</subject><subject>Cyclophosphamide - therapeutic use</subject><subject>Disease Models, Animal</subject><subject>Fluconazole - therapeutic use</subject><subject>Male</subject><subject>Mice</subject><subject>Mycoses - drug therapy</subject><subject>Mycoses - microbiology</subject><subject>Random Allocation</subject><subject>Trichosporon - isolation &amp; purification</subject><subject>Trichosporon - pathogenicity</subject><subject>动物模型</subject><subject>毛孢子菌</subject><subject>致病性</subject><subject>阿萨希丝孢酵母</subject><issn>0366-6999</issn><issn>2542-5641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNpNkMtOwzAQRS0EoqXwCyhiwS4wfsdLhHhJlWBRiaXlxE7j0sQlToXK1-PS8ljNaHTPjH0QyjBcYVDyGgCIohRyAlBgAgTyNMLiAI0JZyTnguFDNAYqRC6UUiN0EuMiQZxLcYxGWOFCcsXH6PXFDE2Yu85Xfthkoc5mva-aEFehD11momm8z3zqsnbd-85lbbBuuQ1aH6NrfWcGZ7PhHxWij6foqDbL6M72dYJm93ez28d8-vzwdHszzStG8JAzpqyRogQrVaGEpJQVBZRK1tZyVxtqLHAjcaWgZIxV4IoalOBy-xVS0Am63K39MF1turlehHXfpYP6s6naxVYPYUlMCha7YNWHGHtX61XvW9NvNAa9dap_nOpfp_rbaULPd-hqXbbO_oF7iSlwsd_dhG7-7tMzSlO91X7pNFFAgSpMvwDy9n1A</recordid><startdate>20081220</startdate><enddate>20081220</enddate><creator>Yang, Rong-ya</creator><creator>Wang, Wen-ling</creator><creator>Ao, Jun-hong</creator><creator>Hao, Zhen-feng</creator><creator>Zhang, Jie</creator><creator>Wang, Cong-min</creator><general>Department of Dermatology, General Hospital of Beijing Military Region of PLA, Beijing 100700, China</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope></search><sort><creationdate>20081220</creationdate><title>Pathogenicity of Trichosporon asahii in a murine model of disseminated trichosporonosis</title><author>Yang, Rong-ya ; Wang, Wen-ling ; Ao, Jun-hong ; Hao, Zhen-feng ; Zhang, Jie ; Wang, Cong-min</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-449da76b0d798967334880b97fdd5efa3ad05a71c90b444c0e8f096570255283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Amphotericin B - therapeutic use</topic><topic>Animals</topic><topic>Antifungal Agents - therapeutic use</topic><topic>Cyclophosphamide - therapeutic use</topic><topic>Disease Models, Animal</topic><topic>Fluconazole - therapeutic use</topic><topic>Male</topic><topic>Mice</topic><topic>Mycoses - drug therapy</topic><topic>Mycoses - microbiology</topic><topic>Random Allocation</topic><topic>Trichosporon - isolation &amp; purification</topic><topic>Trichosporon - pathogenicity</topic><topic>动物模型</topic><topic>毛孢子菌</topic><topic>致病性</topic><topic>阿萨希丝孢酵母</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Rong-ya</creatorcontrib><creatorcontrib>Wang, Wen-ling</creatorcontrib><creatorcontrib>Ao, Jun-hong</creatorcontrib><creatorcontrib>Hao, Zhen-feng</creatorcontrib><creatorcontrib>Zhang, Jie</creatorcontrib><creatorcontrib>Wang, Cong-min</creatorcontrib><collection>维普_期刊</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><jtitle>Chinese medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Rong-ya</au><au>Wang, Wen-ling</au><au>Ao, Jun-hong</au><au>Hao, Zhen-feng</au><au>Zhang, Jie</au><au>Wang, Cong-min</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pathogenicity of Trichosporon asahii in a murine model of disseminated trichosporonosis</atitle><jtitle>Chinese medical journal</jtitle><addtitle>Chinese Medical Journal</addtitle><date>2008-12-20</date><risdate>2008</risdate><volume>121</volume><issue>24</issue><spage>2557</spage><epage>2560</epage><pages>2557-2560</pages><issn>0366-6999</issn><eissn>2542-5641</eissn><abstract>Background In recent years, superficial and deep mycoses caused by trichosporon were occasionally reported. In 2001, we reported the first case of disseminated trichosporonosis caused by Trichosporon asahfi (T. asahii) in China. In this study, the pathogenicity of T. asahii was investigated in a murine model of disseminated trichosporonosis. Methods Seventy-five mice were randomly divided into 7 groups. Each group was inoculated with T. asahii, through intradermal, gastrointestinal tract or intravenous injection. The mice in the experimental groups were given an intraperitoneal injection of cyclophosphamide (CY) to induce granulocytopenia. Mice in the therapeutic group were given both liposomal amphotericin B and fluconazole. The main viscera of the mice were examined by means of tissue culture and pathologic sections. Results In the two intravenous inoculation groups, T. asahfi was isolated from at least one organ in 10 of the 12 granulocytopenic mice and 2 of the 14 immunocompetent mice. Two of the 7 mice in the granulocytopenia group presented with lesions in the inoculation position, but none of the 30 mice in the granulocytopenia and the control group which were inoculated intradermally or through the gastrointestinal tract had viscera infection. In the therapeutic group, the ratio of consequently dead mice, the number of involved viscera, and the incidence of systemic infection were significantly less than the untreated group. Acute purulent inflammation and granulomatous inflammation were the main pathological changes in the course of the infection. Arthrospores and filaments were found in the focus. Conclusions T. asahii is an opportunistic pathogen that causes cutaneous and visceral infections in immunologically impaired hosts. An immunocompetent host was to be infected by the invading T. asahii. Several organs, namely the liver, lungs, kidneys, spleen and heart, were predisposed. The therapy of combining liposomal amphotericin B with fluconazole can prevent the host from an infection and inhibit the diffusion of the infection.</abstract><cop>China</cop><pub>Department of Dermatology, General Hospital of Beijing Military Region of PLA, Beijing 100700, China</pub><pmid>19187595</pmid><doi>10.1097/00029330-200812020-00016</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0366-6999
ispartof Chinese medical journal, 2008-12, Vol.121 (24), p.2557-2560
issn 0366-6999
2542-5641
language eng
recordid cdi_wanfang_journals_zhcmj200824016
source HEAL-Link subscriptions: Lippincott Williams & Wilkins
subjects Amphotericin B - therapeutic use
Animals
Antifungal Agents - therapeutic use
Cyclophosphamide - therapeutic use
Disease Models, Animal
Fluconazole - therapeutic use
Male
Mice
Mycoses - drug therapy
Mycoses - microbiology
Random Allocation
Trichosporon - isolation & purification
Trichosporon - pathogenicity
动物模型
毛孢子菌
致病性
阿萨希丝孢酵母
title Pathogenicity of Trichosporon asahii in a murine model of disseminated trichosporonosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T19%3A59%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pathogenicity%20of%20Trichosporon%20asahii%20in%20a%20murine%20model%20of%20disseminated%20trichosporonosis&rft.jtitle=Chinese%20medical%20journal&rft.au=Yang,%20Rong-ya&rft.date=2008-12-20&rft.volume=121&rft.issue=24&rft.spage=2557&rft.epage=2560&rft.pages=2557-2560&rft.issn=0366-6999&rft.eissn=2542-5641&rft_id=info:doi/10.1097/00029330-200812020-00016&rft_dat=%3Cwanfang_jour_cross%3Ezhcmj200824016%3C/wanfang_jour_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c421t-449da76b0d798967334880b97fdd5efa3ad05a71c90b444c0e8f096570255283%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/19187595&rft_cqvip_id=29030391&rft_wanfj_id=zhcmj200824016&rfr_iscdi=true